![Matthias Blüher MD](https://res.cloudinary.com/els-assets/image/upload/c_fill_pad,f_auto,g_auto,h_150,q_auto,w_120/v1/practice-update/remote-media/contentimage/32311.jpg)
Matthias Blüher MD
Professor of Obesity Medicine and Director, Helmholtz Institute for Metabolism, Obesity and Vasculature, Munich, Germany; Faculty of Medicine, University of Leipzig, Leipzig, Germany , Leipzig, GermanyMatthias Blüher is Professor of Obesity Medicine, Director of the Helmholtz Institute for Metabolism, Obesity and Vasculature research at the Helmholtz Center Munich and the University of Leipzig, Germany. He is Speaker of the Collaborative Research Center “Obesity mechanisms” at the University of Leipzig in Leipzig, Germany. Matthias Blüher´s research is focused on the role of adipose tissue function and distribution in insulin resistance, the development of obesity, type 2 diabetes and other metabolic and cardiovascular diseases.
Professor Blüher completed his medical studies at the University of Leipzig and his postdoctoral fellowship at the Joslin Diabetes Centre, Boston, USA. Matthias´ work has been recognised both nationally and internationally, as he is a recipient of the Obesity Research Award of the German Obesity Society 2003, the Ferdinand-Bertram-Prize of the German Diabetes Association 2008, the European Association for the Study of Diabetes (EASD) Rising Star Award (2010), and the Minkowski Prize of the EASD 2015.
Disclosures
Matthias Blüher received honoraria as a consultant and speaker from Amgen, AstraZeneca, Bayer, Boehringer-Ingelheim, Daiichi-Sankyo, Lilly, Novo Nordisk, Novartis, Pfizer and Sanofi.